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Abstract
Zygomycosis is an invasive disease caused by fungi in of the class Zygomycetes. Primary
cutaneous zygomycosis is uncommon. We report a case of post-traumatic most lethal form of
cutaneous zygomycosis (gangrenous cellulitis), which closely resembles necrotizing fasciitis
in a young healthy male patient with polytrauma. Multiple surgical debridements, skin
grafting, and intravenous antifungal therapy were necessary to ultimately eradicate the
infection. The early diagnosis by tissue culture and histopathology study is mandatory to
successfully treat this condition.
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Case Report
A 25-year-old male was involved in amotor vehicle accident; he was referred
to the orthopedic department in our hospital
(King Fahad Central Hospital, Jizan, Saudi
Arabia) on 26 October 2007 with
comminuted fracture of the shaft of the right
femur and fracture of the lower fourth right
tibia just distal to a long broad compression
plate which was fixed one year ago for
comminuted fracture of the proximal part.
This patient was ejected out of the car in a
farm when his car rolled over; he was
otherwise healthy before this accident.
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On arrival, the patient was found to be
febrile with normal pulse rate and blood
pressure, fully conscious, with normal chest
and abdomen. The patient had swelling of
the right thigh with intact skin. A swelling
of the lower third of the leg on the medial
aspect was noticed with superficial
abrasions. The pedal pulses were felt and
the motor function of the right foot was
normal. A below knee cast was applied with
a skin traction on the top of it.
Radiological evaluation by plain x-ray of the
right femur showed comminuted fracture
of the lower third of the right femur with
the junction of the upper two thirds
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(Figure 1), x- ray of the right tibia showed a
long broad compression plate fixed on the
medial border with non-union of the middle
third old fracture and a fresh fracture seen
below the compression plate (Figure 2). This
patient was hospitalized for 73 days, during
the admission period the patient underwent
seven operations, the first surgery was done
3 days after admission, the right femur was
first fixed successfully with an
intramedullary nail, then during the draping
of the right leg pus was seen leaking from a
small puncture wound under the abrasions
on the medial aspect of the lower part of the
leg. Intra-operative decision was made to
debride the leg, removal of the compression
plate and screws and application of external
fixation; with excision of the necrotic tissue
a 4x5 cm oval shape skin defect was created.
Wound swabs and soft tissue for culture
were taken.
Figure 1: Plain x-ray of the right femur showing
comminuted fracture.
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Figure 2: X- ray of the right tibia showing
compression plate fixed on the medial border
with non-union (red arrow) of the middle third
fracture and afresh fracture seen below the plate.
Figure 3: Gangrenous cellulitis demonstrating a
characteristic central blackened necrotic eschar
surrounded by reddish-purple soft tissue
induration.
The tissue culture grew pseudomonas and
acinetobacter pathogens for which
Ceftazidine 1 gm IV X 8 hourly and
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Amikacin 500 mg IV X 12 hourly were
started. Dressing on third postoperative day
revealed necrotic edges of the wound
surrounded by reddish-purple soft tissue
induration and a central black crust covered
with numerous small spores seen grossly,
which raised the suspicion of both
necrotizing fasciitis and fungal infection
(Figure 3)..
Figure 4: Large tissue defect which persisted
after repeated debridements with clean base
ready for skin grafting.
Tissues were sent for histopathology
analysis and for fungal culture looking for
zygomycetes. The histopathology report
showed necrosis, suppuration and fungal
hyphae with characteristic appearance of
zygomycetes (Figures 5, 6, 7 and 8). The
fungal cultures grew Rhizopus species.
Figure 5: Fungal hyphae and colonies (H & E
X 100)
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Figure 6: Necrosis, suppuration and fungal
hyphae (H & E X 100)
Figure 7: Silver stained fungi of zygomycetes
GMS X 200.
Figure 8: PAS Stained fungi of zygomycetes,
typically they are broad, thin walled, and
pleomorphic with irregular nonparallel contour,
due to the little structural s iability/ they are
often folded, twisted, or collapsed (PAS, X
1000).
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Patient's general condition deteriorated as
shown by fever (39.5 °C, and WBC of 41 x
109jL) which prompted the treating
physician to change the antibiotics to
Vancomycin IV 1 gm X 12 hourly, Imipenem
IV 19m X 8 hourly and oral Rifampicin 600
mgdaily.
Multiple surgical debridements were done
till the wound became clean and ready for
split skin grafting (Figure 4), which was done
by the plastic surgeon 40 days from the first
surgical intervention, the graft was taken
nicely and postoperative recovery was
smooth, the femur fracture and tibia fracture
united well (Figures 9, 10, and11). The
patient was followed in the clinic for18
months with complete recovery and no signs
of recurrence of Zygomycosis.
Figure 9: The patient's right leg after complete
healing.
Figure 10: Plain x-ray of the right femur
showed union of the fracture fixed with
Intramedullary nail.
Figure 11: Plain x-ray of the right tibia showed
union of the fractures just before the removal of
external fixator.
165
JT U Med Sc 2009; 4(2)
Lethal form ofprimarycutaneous zygomycosis
Discussion
The zygomycetes are divided into two
orders: the Mucorales and the
Entomophthorales. The order Mucorales is
made up of species from the genera
Rhizopus, Mucor, Rhizomucor, Absidia,
Apophysomyces, Saksenaea, Syncephalastrum,
Cunninghamella, and Cokeromuces', The
Zygomycetes are saprophytic fungi that are
ubiquitous in soil or decaying organic
matcrial-.Thc clinical manifestations of
zygomycosis are rhinocerebral, pulmonary
, cutaneous, gastrointestinal, cardiac and
the rarely isolated cerebral disease",
Zygomycosis is often life-threatening, and
hosts are usually compromised by diabetes
mellitus, malignancy or immunosuppressive
therapy. It has also been reported in
neonates, burn patients, drugs abusers and
patients with hepatic or renal insufficiency' .
Most of these conditions are associated with
impairment of normal leucocyte immune
function. In the setting of normal immunity,
fungal infections are contained by the
concerted effort of monocyte/macrophages
and neutrophilic granulocytes. Macrophages
are primarily responsible for suppression of
spore germination by phagocytosis and
oxidative killing, whereas neutrophils are
able to actively mediate hyphal destruction
and fungal killing by similar mechanisms 5,
6
Cutaneous mucormycosis may develop
from contamination of a preexisting surgical
or traumatic wound or burn site,
hematogenous dissemination, or via direct
extension from adjacent infected
subcutaneous tissues, manifesting in two
clinical presentations; a subacute
/Isuperficial" form and a /Igangrenous"
form. In a review of 117 cases of cutaneous
zygomycosis, no underlying illness was
present in 50% of patients", In particular,
cutaneous involvement was the presented
pattern (19 %) in a review of all English
language reports of zygomycosis.
Penetrating trauma was reported to be the
etiological factor in 34 % of these patients",
Infections due to Rhizopus species have
been described in solid organ transplant
patients who are chronically
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immunosuppressed and in immunologically
normal patients with traumatic or surgical
wounds that become exogenously
contaminatedvtt. Also different species were
reported in leukemic cases and in post-
traumatic healthy children and adults12-21•
Nosocomial Rhizomucor cellulitis and
osteomyelitis complicating post-traumatic
multibacterial infection were reported to be
caused by the use of broad spectrum
antibiotics, hypoalbumenia and anemia
which was treated with liposomal
amphotericin B and surgical debridement--.
The present case was complicated with
bacterial infection, pervious tibia fracture
non union with plate fixation and scarring
tissues in addition to the invasive nature of
the fungal infection with the behavior of
necrotizing fasciitis. Inoculation of an
existing wound with fungal spores produces
a localized infection with signs of acute
inflammation, including tissue swelling,
erythema, pus, and abscess formatiori'" 23-24.
The initial stage may mimic a necrotizing
bacterial infection; however, black eschars
and deep ulcerations ensue as the disease
advances->. Necrotizing fasciitis due to
zygomycosis is often potentially limb- and
life-threatening infection26-29• Current case is
that of primary cutaneous zygomycosis
infection because of the presences of the skin
abrasion and soil contamination, which is
reported to occur rapidly and become
invasive in up to 50% of cases involved in
extensive soil contamination". Rhizopus
species was cultured being the most
commonly recovered 47% in human
zygomycosis. However, culture was positive
in only 52% of the autopsy cases found to
have fungal infections and only 30% of
surgical specimens in which fungi were
identified by direct examination.
Aggressive surgical approach was followed
with immediate and repeated surgical
debridements in the operating theater31-34•
Usually this approach leaves a large soft
tissue defect that should be covered by the
plastic surgeon. A review of the literature
yields a survival rate of only approximately
33% after /Iradical surgical excision" or
amputation and amphotericin B
administration'".
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The antifungal Amphotericin B was well
tolerated by the patient which has classically
been the agent of choice for zygomycosis,
based on in vitro and clinical studies36-39•
However, in the current era, lipid
formulations of amphotericin B are the
mainstay of antifungal therapy against
zygomycetes40-42• Treatment with lipid-
based amphotericin B formulations have
fewer toxic side effects, especially on renal
functions', Posaconazole seems a promising
antifungal drug especially in disseminated
forms of zygomycosis44-45 • Rifampicin was
given in addition to amphotericin B to create
synergistic effect but there is no in vitro
conclusive clinical data to recommend the
routine use of such combinatiorre-v.
In conclusion, post-traumatic primary
gangrenous cellulitis zygomycosis, can
occur in healthy individuals, early diagnosis
with high index of suspicion, deep tissue
biopsy for culture and histopathology study
can change the prognosis. Aggressive
surgical approach with combination of
antifungal therapy is the choice of
treatment, the need for skin coverage by
plastic surgeon is almost universal in all
cases due to the large skin defect.
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